Ziprasidon (Swedish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ziprasidon" in Swedish language version.

refsWebsite

Global rank Swedish rank

8google.se

2,848^th place

23^rd place

8web.archive.org

1^st place

4nih.gov

4^th place

17^th place

4doi.org

2^nd place

14^th place

3fda.gov

447^th place

1,667^th place

2icis.com

low place

2lakemedelsverket.se

low place

155^th place

2pfizer.com

low place

1austinpublishinggroup.com

low place

1thepharmaletter.com

low place

1isctm.org

low place

1btpnews.com

low place

1prnewswire.com

406^th place

1,382^nd place

1dr-bob.org

low place

1cnn.com

28^th place

57^th place

1cision.com

6,491^st place

140^th place

1viska.se

low place

1fass.se

low place

112^th place

1la-press.com

low place

1health.wa.gov.au

low place

1files.wordpress.com

869^th place

990^th place

1wiley.com

222^nd place

202^nd place

1hindawi.com

6,828^th place

7,600^th place

1law360.com

6,282^nd place

low place

1wsj.com

79^th place

342^nd place

austinpublishinggroup.com

Ayano, Getinet. ”Second Generation Antipsychotics: Pharmacodynamics, Therapeutic Effects Indications and Associated Metabolic Side Effects: Review of Articles”. Journal of Schizophrenia Research. http://austinpublishinggroup.com/schizophrenia/fulltext/schizophrenia-v3-id1027.php.

btpnews.com

”Ziprasidone (Geodon)”. www.btpnews.com. Arkiverad från originalet den 2016-12-21. https://web.archive.org/web/20161221040032/http://www.btpnews.com/article/2001/06/01/Ziprasidone-Geodon.

cision.com

news.cision.com

”Zeldox ger effektiv dämpning av maniska symtom vid bipolär sjukdom”. News Powered by Cision. http://news.cision.com/se/pfizer/r/zeldox-ger-effektiv-dampning-av-maniska-symtom-vid-bipolar-sjukdom,c177350.

cnn.com

money.cnn.com

writer, By Aaron Smith, CNN/Money staff. ”Pfizer's antipsychotic Geodon approved in Europe - Nov. 1, 2005”. money.cnn.com. http://money.cnn.com/2005/11/01/news/fortune500/geodon/.

doi.org

dx.doi.org

Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; et al. (2013). ”Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis”. The Lancet 382 (9896): sid. 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019.
Gardner, David M; Murphy, Andrea L; Kutcher, Stan; Beaulieu, Serge; Carandang, Carlo; Labelle, Alain; Lalonde, Pierre; Malla, Ashok; et al. (24 januari 2013). ”Evidence review and clinical guidance for the use of ziprasidone in Canada”. Annals of General Psychiatry 12: sid. 1. doi:10.1186/1744-859X-12-1. PMID 23347694. PMC: PMC3564821. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564821/.
Stahl SM, Mignon L, Meyer JM (15 december 2009). ”Which comes first: atypical antipsychotic treatment or cardiometabolic risk?”. Acta Psychiatr Scand "119" (3): ss. 171–9. doi:10.1111/j.1600-0447.2008.01334.x. PMID 19178394. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-0447.2008.01334.x.
Panariello, Fabio; Luca, Vincenzo De; Bartolomeis, Andrea de (2011). ”Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies”. Schizophrenia Research and Treatment 2011: sid. 1–16. doi:10.1155/2011/459284. https://www.hindawi.com/journals/schizort/2011/459284/.

dr-bob.org

”Psycho-Babble Medication Thread 73765”. www.dr-bob.org. http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010804/msgs/73844.html.

fass.se

”Ziprasidon - FASS Allmänhet”. www.fass.se. https://www.fass.se/LIF/product?userType=2&nplId=20100729000030.

fda.gov

accessdata.fda.gov

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20-919_geodon_biopharmr.pdf

files.wordpress.com

farmakologiforantipsykotiska.files.wordpress.com

https://farmakologiforantipsykotiska.files.wordpress.com/2020/08/jm070516u.pdf^{[död länk]}

google.se

books.google.se

Schatzberg, Alan F.; Nemeroff, Charles B. (2009). ”The American Psychiatric Publishing Textbook of Psychopharmacology”. The American Psychiatric Publishing Textbook of Psychopharmacology. American Psychiatric Pub. https://books.google.se/books?id=Xx7iNGdV25IC&pg=PA641&redir_esc=y#v=onepage&q&f=false.
Lemke, Thomas L.; Williams, David A. (24 januari 2012). ”Foye's Principles of Medicinal Chemistry”. Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. https://books.google.se/books?id=Sd6ot9ul-bUC&pg=PA465&lpg=PA465&dq=#v=onepage&q&f=false.
Morphy, J. Richard; Harris, C. John (2012). ”Designing Multi-target Drugs”. Designing Multi-target Drugs. Royal Society of Chemistry. https://books.google.se/books?id=T1QcjxnP6noC&pg=PA263&lpg=PA263&dq=#v=onepage&q&f=false.
Li, Jie Jack; Johnson, Douglas S.; Sliskovic, Drago R.; Roth, Bruce D. (27 december 2004). ”Contemporary Drug Synthesis”. Contemporary Drug Synthesis. John Wiley & Sons. https://books.google.se/books?id=fsKKI82uqK8C&pg=PA101&lpg=PA101&dq#v=onepage&q&f=false.
Strom, Brian L.; Kimmel, Stephen E.; Hennessy, Sean (5 mars 2012). ”Pharmacoepidemiology”. Pharmacoepidemiology. John Wiley & Sons. https://books.google.se/books?id=fS7ygS9dnb8C&pg=PA88&lpg=PA88&dq=#v=onepage&q&f=false.
Schatzberg, Alan F.; Nemeroff, Charles B. (2013). ”Essentials of Clinical Psychopharmacology”. Essentials of Clinical Psychopharmacology. American Psychiatric Pub. https://books.google.se/books?id=26MyfLffpkgC&pg=PA341&lpg=PA341&dq#v=onepage&q&f=false.
Seifert, Roland; Wieland, Thomas (12 maj 2006). ”G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity”. G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity. John Wiley & Sons. https://books.google.se/books?id=xogTUkmT7Q8C&pg=PA227&lpg=PA227&dq#v=onepage&q&f=false.
Shiromani, Priyattam; Horvath, Tamas; Redline, Susan; Cauter, Eve Van (1 juni 2012). ”Sleep Loss and Obesity: Intersecting Epidemics”. Sleep Loss and Obesity: Intersecting Epidemics. Springer Science & Business Media. https://books.google.se/books?id=eobDZ1d_dvAC&pg=PA39&lpg=PA39&dq#v=onepage&q&f=false.

health.wa.gov.au

ww2.health.wa.gov.au

https://ww2.health.wa.gov.au/~/media/Files/Corporate/general%20documents/WATAG/WAPDC/Ziprasidone-unzipped.pdf

hindawi.com

Panariello, Fabio; Luca, Vincenzo De; Bartolomeis, Andrea de (2011). ”Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies”. Schizophrenia Research and Treatment 2011: sid. 1–16. doi:10.1155/2011/459284. https://www.hindawi.com/journals/schizort/2011/459284/.

icis.com

”Sweden approves Pfizer's antipsychotic drug 'Zeldox'”. Sweden approves Pfizer's antipsychotic drug 'Zeldox'. http://www.icis.com/resources/news/2000/09/05/120098/sweden-approves-pfizer-s-antipsychotic-drug-zeldox-/.
”Sweden approves Pfizer's antipsychotic drug 'Zeldox'”. Sweden approves Pfizer's antipsychotic drug 'Zeldox'. https://www.icis.com/resources/news/2000/09/05/120098/sweden-approves-pfizer-s-antipsychotic-drug-zeldox-/.

isctm.org

https://isctm.org/public_access/Autumn2017/Presentation/930-J-Geier.pdf

la-press.com

”Arkiverade kopian”. Arkiverad från originalet den 20 februari 2013. https://web.archive.org/web/20130220000739/http://www.la-press.com/redirect_file.php?fileId=3361&filename=2474-JCNSD-Ziprasidone-Hydrocloride:-What-Role-in-the-Management-of-Schizophrenia.pdf&fileType=pdf. Läst 14 mars 2017.

lakemedelsverket.se

”Arkiverade kopian”. Arkiverad från originalet den 10 juli 2016. https://web.archive.org/web/20160710121929/https://lakemedelsverket.se/upload/om-lakemedelsverket/publikationer/information-fran-lakemedelsverket/Info_fr_LV_2001-2.pdf. Läst 10 juli 2016.
”Arkiverade kopian”. Arkiverad från originalet den 4 januari 2017. https://web.archive.org/web/20170104090519/https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/bakg_dok/L%C3%A4kemedelsbehandling%20vid%20schizofren_bakgrund.pdf. Läst 7 oktober 2017.

law360.com

”Pfizer Slams Appeal In Off-Label FCA Case In 1st Circ. - Law360”. www.law360.com. http://www.law360.com/articles/860912/pfizer-slams-appeal-in-off-label-fca-case-in-1st-circ.

nih.gov

ncbi.nlm.nih.gov

Sheehan, Valerie (1 oktober 2003). ”Ziprasidone mesylate (Geodon for injection): the first injectable atypical antipsychotic medication”. Proceedings (Baylor University. Medical Center) 16 (4): sid. 497–501. PMID 16278769. PMC: PMC1214571. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1214571/.
Leucht, Stefan; Cipriani, Andrea; Spineli, Loukia; Mavridis, Dimitris; Örey, Deniz; Richter, Franziska; Samara, Myrto; Barbui, Corrado; et al. (2013). ”Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis”. The Lancet 382 (9896): sid. 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019.
Gardner, David M; Murphy, Andrea L; Kutcher, Stan; Beaulieu, Serge; Carandang, Carlo; Labelle, Alain; Lalonde, Pierre; Malla, Ashok; et al. (24 januari 2013). ”Evidence review and clinical guidance for the use of ziprasidone in Canada”. Annals of General Psychiatry 12: sid. 1. doi:10.1186/1744-859X-12-1. PMID 23347694. PMC: PMC3564821. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564821/.
Stahl SM, Mignon L, Meyer JM (15 december 2009). ”Which comes first: atypical antipsychotic treatment or cardiometabolic risk?”. Acta Psychiatr Scand "119" (3): ss. 171–9. doi:10.1111/j.1600-0447.2008.01334.x. PMID 19178394. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-0447.2008.01334.x.

pfizer.com

”Material Safety Data Sheet” (på engelska) ( PDF). Pfizer. sid. 1. Arkiverad från originalet den 9 maj 2012. https://web.archive.org/web/20120509002506/http://www.pfizer.com/files/products/material_safety_data/400.pdf. Läst 16 augusti 2021.

labeling.pfizer.com

http://labeling.pfizer.com/ShowLabeling.aspx?id=584#page=1

prnewswire.com

Inc, Pfizer. ”Pfizer to Launch Zeldox in 9 European Union Countries Beginning Next Month”. www.prnewswire.com. Arkiverad från originalet den 2017-09-18. https://web.archive.org/web/20170918155309/http://www.prnewswire.com/news-releases/pfizer-to-launch-zeldox-in-9-european-union-countries-beginning-next-month-76154202.html. Läst 19 november 2016.

thepharmaletter.com

Letter, The Pharma. ”Pfizer gains Swedish OK for intramuscular Zeldox - Pharmaceutical indu”. www.thepharmaletter.com. http://www.thepharmaletter.com/article/pfizer-gains-swedish-ok-for-intramuscular-zeldox.

viska.se

”Hur många får neuroleptika i Sverige?”. Bli friskare, bli Viskare!. http://www.viska.se/nya-lakemedel/lakemedel/6192-hur-manga-far-neuroleptika-i-sverige.

web.archive.org

”Material Safety Data Sheet” (på engelska) ( PDF). Pfizer. sid. 1. Arkiverad från originalet den 9 maj 2012. https://web.archive.org/web/20120509002506/http://www.pfizer.com/files/products/material_safety_data/400.pdf. Läst 16 augusti 2021.
”Arkiverade kopian”. Arkiverad från originalet den 10 juli 2016. https://web.archive.org/web/20160710121929/https://lakemedelsverket.se/upload/om-lakemedelsverket/publikationer/information-fran-lakemedelsverket/Info_fr_LV_2001-2.pdf. Läst 10 juli 2016.
”Ziprasidone (Geodon)”. www.btpnews.com. Arkiverad från originalet den 2016-12-21. https://web.archive.org/web/20161221040032/http://www.btpnews.com/article/2001/06/01/Ziprasidone-Geodon.
Inc, Pfizer. ”Pfizer to Launch Zeldox in 9 European Union Countries Beginning Next Month”. www.prnewswire.com. Arkiverad från originalet den 2017-09-18. https://web.archive.org/web/20170918155309/http://www.prnewswire.com/news-releases/pfizer-to-launch-zeldox-in-9-european-union-countries-beginning-next-month-76154202.html. Läst 19 november 2016.
https://web.archive.org/web/20160808111017/http://www.irf.dk/en/reviews/zeldox_ziprasidone.htm
”Arkiverade kopian”. Arkiverad från originalet den 20 februari 2013. https://web.archive.org/web/20130220000739/http://www.la-press.com/redirect_file.php?fileId=3361&filename=2474-JCNSD-Ziprasidone-Hydrocloride:-What-Role-in-the-Management-of-Schizophrenia.pdf&fileType=pdf. Läst 14 mars 2017.
https://web.archive.org/web/20160917003357/https://www.fda.gov/ohrms/dockets/ac/00/backgrd/3619b1a.pdf
”Arkiverade kopian”. Arkiverad från originalet den 4 januari 2017. https://web.archive.org/web/20170104090519/https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/bakg_dok/L%C3%A4kemedelsbehandling%20vid%20schizofren_bakgrund.pdf. Läst 7 oktober 2017.

wiley.com

onlinelibrary.wiley.com

Stahl SM, Mignon L, Meyer JM (15 december 2009). ”Which comes first: atypical antipsychotic treatment or cardiometabolic risk?”. Acta Psychiatr Scand "119" (3): ss. 171–9. doi:10.1111/j.1600-0447.2008.01334.x. PMID 19178394. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-0447.2008.01334.x.

wsj.com

Dooren, Jennifer Corbett (21 april 2010). ”FDA Warns Pfizer About Pediatric Trials of Geodon”. FDA Warns Pfizer About Pediatric Trials of Geodon. http://www.wsj.com/articles/SB10001424052748704448304575196264170067920.